OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 05/09/2025 at 18:00, 1 year 4 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC converteert 4 obligaties in Oxurion, resulterend in EUR 100.000 kapitaalverhoging. Oxurion verstrekt 1.521.372 gewone aandelen. Meer info op www.oxurion.com

Kapitaalverhoging Atlas Special Opportunities Aandelen Oxurion Innovatieve Geneesmiddelen
BRIEF

published on 04/25/2025 at 18:35, 1 year 5 months ago

Oxurion Arrête une Transaction de 2024 et Continue les Négociations pour une Nouvelle Acquisition

Acquisition Négociations CRO Oxurion Biométrie
BRIEF

published on 04/25/2025 at 18:35, 1 year 5 months ago

Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition

Acquisition Negotiations CRO Oxurion Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 1 year 5 months ago

Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025
Oxurion NV (Euronext Brussels: OXUR) stops negotiations for majority stake acquisition in French CRO, continues talks for majority stake in CRO specializing in biometrics and advanced data management. Market updates to follow

Majority Stake Acquisition Clinical Studies CRO Oxurion NV Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 1 year 5 months ago

Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025
Oxurion NV halts acquisition of French CRO, pursues deal with biometrics CRO to expand capabilities in clinical data management. Progress updates to follow

Acquisition CRO Oxurion NV Clinical Data Management Biometrics
BRIEF

published on 04/11/2025 at 20:05, 1 year 5 months ago

Oxurion Publie son Rapport Annuel 2024 et Convoque son Assemblée Générale

Déclarations Prospectives Rapport Annuel 2024 Oxurion NV Thérapies Ophtalmologiques Assemblées Actionnaires
BRIEF

published on 04/11/2025 at 20:05, 1 year 5 months ago

Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting

Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
PRESS RELEASE

published on 04/11/2025 at 20:05, 1 year 5 months ago

Publication Annual Report - Annual Shareholders' Meeting
Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease

Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease
PRESS RELEASE

published on 04/11/2025 at 20:00, 1 year 5 months ago

Publicatie jaarverslag - Jaarlijkse Algemene Vergadering
Oxurion NV publice son rapport annuel 2024, convoque son assemblée annuelle d'actionnaires et se concentre sur les thérapies ophtalmologiques

Rapport Annuel 2024 Oxurion NV Assemblée Annuelle Thérapies Ophtalmologiques Biofarmaceutique
BRIEF

published on 04/04/2025 at 14:05, 1 year 5 months ago

Report de l'Assemblée Générale d'Oxurion

Assemblée Générale Biopharmaceutique Report Oxurion Thérapies Ophtalmologiques

Published on 09/26/2026 at 01:00, 9 hours 3 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 9 hours 3 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 11 hours 48 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 16 hours 33 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 19 hours 3 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 07:45, 2 hours 18 minutes ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 10 hours 2 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 15 hours 33 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 15 hours 48 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 16 hours 3 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26

View all EQS

Published on 09/26/2026 at 07:00, 3 hours 3 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 16 hours 3 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 16 hours 3 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 16 hours 18 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 16 hours 23 minutes ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE

News